Itraconazole
Trioxal contains the active substance itraconazole, which belongs to the group of thiazole derivatives, and is a broad-spectrum antifungal agent.
in the event of taking a higher dose of Trioxal than recommended, you should immediately consult a doctor.
While taking Trioxal, it is contraindicated to take certain other medications (see "Trioxal and other medications").
Before starting Trioxal, you should discuss with your doctor if any of the following situations apply to you.
If you experience any of the following symptoms while taking Trioxal, you should inform your doctor.
You should inform your doctor or pharmacist about all medications you are currently taking or have recently taken, as well as any medications you plan to take.
Medications that should not be taken with Trioxal:
If you are taking any of these medications, it is contraindicated to take Trioxal. If you are taking Trioxal, you should not start taking these medications until at least 2 weeks after stopping Trioxal.
Medications whose use with Trioxal is not recommended, unless your doctor considers it necessary:
Other medications that interact with Trioxal:
If you are taking any of these medications, it may be necessary to adjust the dose of these medications or Trioxal.
Medications that affect the absorption of itraconazole
Medications that reduce stomach acid can disrupt the absorption of itraconazole released from Trioxal capsules. Therefore, antacids can be taken at least 1 hour before or at least 2 hours after taking Trioxal. For the same reason, if you are taking medications that reduce gastric acid secretion, you should take Trioxal with a "cola"-type drink (non-diet).
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medication.
Trioxal should not be taken during pregnancy, except in life-threatening situations where the potential benefits of treatment outweigh the potential risks to the fetus.
Women of childbearing age taking Trioxal should use effective contraceptive methods until the first menstrual period after stopping Trioxal.
Itraconazole passes into breast milk in very small amounts. Your doctor will decide whether the expected benefits of taking Trioxal during breastfeeding outweigh the risks to the baby. If in doubt, you should not breastfeed.
Trioxal can sometimes cause dizziness, blurred or double vision, or hearing loss. If you experience these symptoms, you should not drive or operate machinery.
One hard capsule contains 265.3 mg of sucrose in granules, containing 80.0-91.5% sucrose. If you have been diagnosed with intolerance to some sugars, you should consult your doctor before taking this medication.
This medication should always be taken as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Trioxal is taken orally, immediately after a full meal. The capsules should be swallowed whole.
Dosage for adults
Genital infections | ||
Indication | Dosage | Duration of treatment |
Vaginal candidiasis and vulvovaginal candidiasis | 200 mg twice a day or 200 mg once a day | 1 day or 3 days |
Skin, mucous membrane, or eye infections | ||
Indication | Dosage | Duration of treatment |
Skin candidiasis | 200 mg once a day or 100 mg once a day | 7 days or 15 days |
Fungal infection of areas with increased skin keratinization, such as athlete's foot and hand fungal infections | 200 mg twice a day or 100 mg once a day | 7 days or 30 days |
Pityriasis versicolor | 200 mg once a day | 7 days |
Seborrheic dermatitis (severe or recurrent) | 200 mg once a day | 7 days# |
# after 1 month as maintenance treatment, itraconazole can be given in a dose of 200 mg per day for the first 2 days of each subsequent month; the duration of treatment depends on the patient's response to treatment | ||
Oral candidiasis | 100 mg once a day | 15 days |
In some patients with impaired immunity (e.g., patients with neutropenia, AIDS, or organ transplantation), the doctor may recommend doubling the dose. | ||
Fungal keratitis | 200 mg once a day | 21 days. The duration of treatment depends on the patient's response to treatment |
Fungal nail infections caused by dermatophytes and/or yeasts | |||||||||
Pulse therapy | |||||||||
It involves taking two capsules twice a day (200 mg twice a day) for one week. In the treatment of fingernail fungal infections, two cycles are used. In the treatment of toenail fungal infections, three cycles are used. The treatment periods (cycles) are separated by a three-week break, during which the medication is not taken. The response to treatment becomes visible after the end of treatment and after the nail has grown back. | |||||||||
Location of fungal nail infection | Week
| Week
| Week
| Week
| Week
| Week
| Week
| Week
| Week
|
Toenail fungal infections or with fingernail fungal infections | Cycle 1. | Break in taking itraconazole | Cycle 2. | Break in taking itraconazole | Cycle 3. | ||||
Only fingernail fungal infections | Cycle 1. | Break in taking itraconazole | Cycle 2. |
Continuous treatment | ||
Location of fungal nail infection | Dosage | Duration of treatment |
Only toenail fungal infections or with fingernail fungal infections | 200 mg once a day | 3 months |
The elimination of itraconazole from the skin and nails is slower than from the blood. Optimal treatment results in terms of clinical symptoms and microbiological test results are achieved within 2 to 4 weeks after the end of treatment for skin infections and within 6 to 9 months after the end of treatment for nail infections.
Systemic fungal infections | |||
Indication | Dosage | Average duration of treatment1 | Notes |
Aspergillosis | 200 mg once a day | 2 to 5 months | The doctor will increase the dose to 200 mg twice a day if the lesions are deep or widespread |
Candidiasis | 100 mg to 200 mg once a day | 3 weeks to 7 months | The doctor will increase the dose to 200 mg twice a day if the lesions are deep or widespread |
Cryptococcosis (without meningitis) | 200 mg once a day | 2 months to 1 year | |
Cryptococcal meningitis | 200 mg twice a day | 2 months to 1 year | The doctor will consider maintaining maintenance treatment |
Histoplasmosis | from 200 mg once a day to 200 mg twice a day | 8 months | |
Blastomycosis | from 100 mg once a day to 200 mg twice a day | 6 months | |
Sporotrichosis, lymphatic-cutaneous and cutaneous | 100 mg once a day | 3 months | |
Paracoccidioidomycosis | 100 mg once a day | 6 months | There is no data on the effectiveness of Trioxal capsules in the treatment of paracoccidioidomycosis in patients with AIDS |
Chromomycosis | 100 to 200 mg once a day | 6 months | |
1 The doctor will adjust the duration of treatment according to the patient's response to treatment |
Trioxal can be used in children only if the doctor decides that the expected benefits outweigh the risks.
In the event of taking a higher dose of Trioxal than recommended, you should immediately consult a doctor.
You should not take a double dose to make up for a missed dose.
You should continue taking Trioxal for as long as your doctor recommends. You should not stop treatment on your own, even if you feel better.
If you have any further questions about taking this medication, you should consult your doctor or pharmacist.
Like all medications, Trioxal can cause side effects, although not everybody gets them.
In clinical trials involving 8499 patients taking itraconazole, the following side effects occurred in at least 1 in 100 patients: headache, nausea, and abdominal pain.
In these clinical trials, the following side effects occurred less frequently than in 1 in 100 patients taking itraconazole: nasal passage inflammation, sinusitis, upper respiratory tract infections, low white blood cell count, hypersensitivity, taste disturbances, numbness, paresthesia (sensory disturbances, tingling, numbness, burning sensation on the skin), tinnitus, constipation, diarrhea, dyspepsia, bloating, vomiting, abnormal liver function, high bilirubin levels in the blood, itching, rash, hives, polyuria, erectile dysfunction, menstrual disorders, and edema.
In clinical trials involving children and adolescents (aged 1 to 17), the following side effects occurred more frequently than in 1 in 100 patients: headache, vomiting, abdominal pain, diarrhea, liver function disorders, hypotension, nausea, and hives.
If you experience any side effects, including those not listed in this leaflet, you should inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website:
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medication.
Medications should be kept out of the sight and reach of children.
Store in a temperature below 30°C.
Do not use this medication after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot/LOT means the batch number.
Medications should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
Trioxal is a hard gelatin capsule (size 0), filled with yellow-beige spherical microgranules. The cap and body are opaque, green in color.
Aluminum/Aluminum blisters, in a cardboard box.
The pack contains 4, 14, 15, 28, or 84 capsules.
Not all pack sizes may be marketed.
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
LICONSA SA
Avda. Miralcampo, No 7, E-19200 Azuqueca de Henares (Guadalajara)
Spain
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.